These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30945919)

  • 21. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of vocational participation and global role functioning in help-seeking young adults, from neurocognitive, demographic and clinical variables.
    Cairns AJ; Kavanagh DJ; Dark F; McPhail SM
    J Affect Disord; 2017 Oct; 221():158-164. PubMed ID: 28646712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond these walls: Can psychosocial clubhouses promote the social integration of adults with serious mental illness in the community?
    Gumber S; Stein CH
    Psychiatr Rehabil J; 2018 Mar; 41(1):29-38. PubMed ID: 28368136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relative contribution of neurocognition and social cognition to 6-month vocational outcomes following Individual Placement and Support in first-episode psychosis.
    Allott KA; Cotton SM; Chinnery GL; Baksheev GN; Massey J; Sun P; Collins Z; Barlow E; Broussard C; Wahid T; Proffitt TM; Jackson HJ; Killackey E
    Schizophr Res; 2013 Oct; 150(1):136-43. PubMed ID: 23938175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of cognitive rehabilitation using computer software with individuals living with schizophrenia: A randomized controlled trial in Japan.
    Iwata K; Matsuda Y; Sato S; Furukawa S; Watanabe Y; Hatsuse N; Ikebuchi E
    Psychiatr Rehabil J; 2017 Mar; 40(1):4-11. PubMed ID: 28182471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia.
    Ojeda N; Peña J; Sánchez P; Elizagárate E; Ezcurra J
    Schizophr Res; 2008 Apr; 101(1-3):225-33. PubMed ID: 18261885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multidimensional measure of participation for adults with serious mental illnesses.
    Chang FH; Coster WJ; Salzer MS; Brusilovskiy E; Ni P; Jette AM
    Disabil Rehabil; 2016; 38(7):695-703. PubMed ID: 26079634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects.
    Laes JR; Sponheim SR
    Schizophr Res; 2006 May; 84(1):121-31. PubMed ID: 16443348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathways to functional outcomes in schizophrenia spectrum disorders: Meta-analysis of social cognitive and neurocognitive predictors.
    Halverson TF; Orleans-Pobee M; Merritt C; Sheeran P; Fett AK; Penn DL
    Neurosci Biobehav Rev; 2019 Oct; 105():212-219. PubMed ID: 31415864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains.
    Alden EC; Cobia DJ; Reilly JL; Smith MJ
    Schizophr Res; 2015 Oct; 168(1-2):273-8. PubMed ID: 26215505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Haining K; Matrunola C; Mitchell L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Psychol Med; 2020 Jan; 50(1):77-85. PubMed ID: 30862319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Clubhouse model for people with severe mental illnesses: Literature review and French experiment].
    Bouvet C; Battin C; Le Roy-Hatala C
    Encephale; 2015 Dec; 41(6):477-86. PubMed ID: 25438970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community participation differences between Black and White adults with serious mental illness.
    Nagata S; Subica AM; Myrick KJ; Green C; Salzer MS
    Am J Orthopsychiatry; 2022; 92(6):702-710. PubMed ID: 36174138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consumer perspectives on physical activity interventions within assertive community treatment programs.
    Huck GE; Finnicum C; Morrison B; Kaseroff A; Umucu E
    Psychiatr Rehabil J; 2018 Dec; 41(4):312-318. PubMed ID: 29999334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social cognition, internalized stigma, and recovery orientation among adults with serious mental illness.
    Cunningham KC; Lucksted A
    Psychiatr Rehabil J; 2017 Dec; 40(4):409-411. PubMed ID: 28447822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.
    Twamley EW; Thomas KR; Burton CZ; Vella L; Jeste DV; Heaton RK; McGurk SR
    Schizophr Res; 2019 Jan; 203():41-48. PubMed ID: 28823720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.